{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T12:52:06Z","timestamp":1765889526036,"version":"build-2065373602"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T00:00:00Z","timestamp":1757376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T00:00:00Z","timestamp":1757376000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"DOI":"10.1007\/s00296-025-05985-2","type":"journal-article","created":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T11:10:04Z","timestamp":1757416204000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Successful treatment of Kimura disease with Mycophenolate Mofetil: a report of two cases and review of the literature"],"prefix":"10.1007","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0951-3171","authenticated-orcid":false,"given":"Mikaela","family":"Wilson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4287-6708","authenticated-orcid":false,"given":"Cyrus C.","family":"Hsia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin","family":"Rowan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0848-130X","authenticated-orcid":false,"given":"Shih-Han Susan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3064-8222","authenticated-orcid":false,"given":"Tony","family":"Ng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leslie N.","family":"Zypchen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-4600-1493","authenticated-orcid":false,"given":"Robert","family":"Bona","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natasha","family":"Dehghan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9551-2951","authenticated-orcid":false,"given":"Luke Y. C.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,9,9]]},"reference":[{"key":"5985_CR1","first-page":"179","volume":"37","author":"T Kimura","year":"1948","unstructured":"Kimura T (1948) On the unusual granulations combined with hyperplastic changes of lymphatic tissue. Trans Soc Pathol Jpn 37:179\u2013180","journal-title":"Trans Soc Pathol Jpn"},{"issue":"4","key":"5985_CR2","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1097\/00000478-200404000-00010","volume":"28","author":"H Chen","year":"2004","unstructured":"Chen H, Thompson LD, Aguilera NS, Abbondanzo SL (2004) Kimura disease: a clinicopathologic study of 21 cases. Am J Surg Pathol 28(4):505\u2013513","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"5985_CR3","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1186\/s12882-018-1123-y","volume":"19","author":"S Ren","year":"2018","unstructured":"Ren S, Li XY, Wang F et al (2018) Nephrotic syndrome associated with Kimura\u2019s disease: a case report and literature review. BMC Nephrol 19(1):316","journal-title":"BMC Nephrol"},{"issue":"6","key":"5985_CR4","doi-asserted-by":"publisher","first-page":"249","DOI":"10.7181\/acfs.2022.01053","volume":"23","author":"WJ Kim","year":"2022","unstructured":"Kim WJ, Kim HK (2022) Current concepts of Kimura disease: pathophysiology and evolution of treatment. Arch Craniofac Surg 23(6):249\u2013255","journal-title":"Arch Craniofac Surg"},{"issue":"4","key":"5985_CR5","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1080\/09546630510044003","volume":"16","author":"YS Wang","year":"2005","unstructured":"Wang YS, Tay YK, Tan E, Poh WT (2005) Treatment of Kimura\u2019s disease with cyclosporine. J Dermatolog Treat 16(4):242\u2013244","journal-title":"J Dermatolog Treat"},{"issue":"8","key":"5985_CR6","first-page":"2219","volume":"7","author":"XR Ma","year":"2014","unstructured":"Ma XR, Xin SJ, Ouyang TX, Ma YT, Chen WY, Chang ML (2014) Successful treatment of Kimura\u2019s disease with leflunomide and methylprednisolone: a case report. Int J Clin Exp Med 7(8):2219\u20132222","journal-title":"Int J Clin Exp Med"},{"issue":"4","key":"5985_CR7","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1159\/000439346","volume":"231","author":"D Kottler","year":"2015","unstructured":"Kottler D, Bar\u00e8te S, Qu\u00e9reux G et al (2015) Retrospective multicentric study of 25 Kimura disease patients: emphasis on therapeutics and shared features with cutaneous IgG4-related disease. Dermatology 231(4):367\u2013377","journal-title":"Dermatology"},{"issue":"7","key":"5985_CR8","doi-asserted-by":"publisher","first-page":"2928","DOI":"10.1016\/j.jaip.2021.02.049","volume":"9","author":"M Kinoshita","year":"2021","unstructured":"Kinoshita M, Ogawa Y, Onaka M, Shimada S, Kawamura T (2021) Mepolizumab-responsive Kimura disease. J Allergy Clin Immunol Pract 9(7):2928\u20132930","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"9","key":"5985_CR9","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1007\/s00277-022-04873-0","volume":"101","author":"VG Szeto","year":"2022","unstructured":"Szeto VG, Chin-Yee B, Dehghani M, Rizkalla K, Licskai C, Hsia CC (2022) Successful treatment of Kimura disease with benralizumab. Ann Hematol 101(9):2099\u20132100","journal-title":"Ann Hematol"},{"issue":"10","key":"5985_CR10","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1007\/s00296-021-04961-w","volume":"41","author":"M Philobos","year":"2021","unstructured":"Philobos M, Perkins A, Karabayas M et al (2021) A real-world assessment of mycophenolate mofetil for remission induction in eosinophilic granulomatosis with polyangiitis. Rheumatol Int 41(10):1811\u20131814","journal-title":"Rheumatol Int"},{"issue":"2","key":"5985_CR11","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.54054","volume":"6","author":"FF Hou","year":"2023","unstructured":"Hou FF, Xie D, Wang J et al (2023) Effectiveness of mycophenolate mofetil among patients with progressive IgA nephropathy: a randomized clinical trial. JAMA Netw Open 6(2):e2254054","journal-title":"JAMA Netw Open"},{"issue":"8S","key":"5985_CR12","doi-asserted-by":"publisher","first-page":"S622","DOI":"10.1097\/RHU.0000000000001704","volume":"27","author":"A Ahrari","year":"2021","unstructured":"Ahrari A, Ahrari A, Chen LYC et al (2021) Kimura disease presenting with new Raynaud phenomenon: a common symptom caused by an uncommon disease. J Clin Rheumatol 27(8S):S622\u2013S624","journal-title":"J Clin Rheumatol"},{"issue":"2","key":"5985_CR13","doi-asserted-by":"publisher","DOI":"10.1002\/jha2.1109","volume":"6","author":"XQ Wang","year":"2025","unstructured":"Wang XQ, Shopsowitz K, Lofroth J et al (2025) Lymphocytic variant hypereosinophilic syndrome: case series from a tertiary referral center in Canada. EJHaem 6(2):e1109","journal-title":"EJHaem"},{"issue":"4","key":"5985_CR14","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1111\/ejh.12842","volume":"98","author":"MN Carruthers","year":"2017","unstructured":"Carruthers MN, Park S, Slack GW et al (2017) IgG4-related disease and lymphocyte-variant hypereosinophilic syndrome: a comparative case series. Eur J Haematol 98(4):378\u2013387","journal-title":"Eur J Haematol"},{"issue":"2","key":"5985_CR15","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1080\/01676830.2024.2358061","volume":"44","author":"M Fenech","year":"2025","unstructured":"Fenech M, Ajanaku A, McCormick A et al (2025) Orbital Kimura disease: maintenance therapy using mycophenolate mofetil. Orbit 44(2):215\u2013222","journal-title":"Orbit"},{"key":"5985_CR16","doi-asserted-by":"publisher","first-page":"1069553","DOI":"10.3389\/fmed.2022.1069553","volume":"9","author":"Q Han","year":"2022","unstructured":"Han Q, Han J, Wang W et al (2022) Case report: Kimura\u2019s disease with minimal degenerative glomerulopathy without eosinophil infiltration responds to mycophenolate mofetil treatment. Front Med 9:1069553","journal-title":"Front Med"},{"key":"5985_CR17","doi-asserted-by":"publisher","first-page":"5103547","DOI":"10.1155\/2022\/5103547","volume":"2022","author":"ZA Natsha","year":"2022","unstructured":"Natsha ZA, Hamarsheh IA, Utt RS, Abu Alrob B, Wahdan AA (2022) Atypical presentation of Kimura\u2019s disease in a male patient: a case report and review of literature. Case Rep Med 2022:5103547","journal-title":"Case Rep Med"},{"key":"5985_CR18","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2020-236366","author":"PK Saravanam","year":"2020","unstructured":"Saravanam PK, Gajendran A, Dinakaran N, Jayaraman D (2020) Oropharyngeal Kimura\u2019s disease: a diagnostic dilemma and therapeutic challenge. BMJ Case Rep. https:\/\/doi.org\/10.1136\/bcr-2020-236366","journal-title":"BMJ Case Rep"},{"issue":"10","key":"5985_CR19","doi-asserted-by":"publisher","first-page":"221","DOI":"10.5414\/CN109086","volume":"88","author":"J Gaillard","year":"2017","unstructured":"Gaillard J, Rotman S, Girardet C, Spertini F (2017) Successful therapy with mycophenolic acid in a membranous glomerulonephritis due to Kimura disease. Clin Nephrol 88(10):221\u2013225","journal-title":"Clin Nephrol"},{"key":"5985_CR20","volume":"2010","author":"MA Fouda","year":"2011","unstructured":"Fouda MA, Gheith O, Refaie A et al (2011) Kimura disease: a case report and review of the literature with a new management protocol. Int J Nephrol 2010:673908","journal-title":"Int J Nephrol"},{"key":"5985_CR21","doi-asserted-by":"publisher","first-page":"A470","DOI":"10.1016\/j.chest.2016.02.489","volume":"149","author":"Z Wang","year":"2016","unstructured":"Wang Z, Wan J, Gong J, Zhang Y (2016) Kimura\u2019s disease in respiratory department: two case reports. Chest 149:A470","journal-title":"Chest"},{"issue":"6","key":"5985_CR22","first-page":"452","volume":"2","author":"N Noel","year":"2009","unstructured":"Noel N, Meignin V, Rosenstingl S, Ronco P, Boffa J-J (2009) Nephrotic syndrome associated with immune thrombocytopenia revealing Kimura\u2019s disease in a non-Asian male. NDT Plus 2(6):452\u2013454","journal-title":"NDT Plus"},{"issue":"3","key":"5985_CR23","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1111\/j.1440-0960.2011.00744.x","volume":"53","author":"XK Liu","year":"2012","unstructured":"Liu XK, Ren J, Wang XH, Li XS, Zhang HP, Zeng K (2012) Angiolymphoid hyperplasia with eosinophilia and Kimura\u2019s disease coexisting in the same patient: evidence for a spectrum of disease. Australas J Dermatol 53(3):e47-50","journal-title":"Australas J Dermatol"},{"issue":"9","key":"5985_CR24","doi-asserted-by":"publisher","first-page":"030006052110409","DOI":"10.1177\/03000605211040976","volume":"49","author":"A Zou","year":"2021","unstructured":"Zou A, Hu M, Niu B (2021) Comparison between Kimura\u2019s disease and angiolymphoid hyperplasia with eosinophilia: case reports and literature review. J Int Med Res 49(9):03000605211040976","journal-title":"J Int Med Res"},{"issue":"3","key":"5985_CR25","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.jaad.2015.10.011","volume":"74","author":"BL Adler","year":"2016","unstructured":"Adler BL, Krausz AE, Minuti A, Silverberg JI, Lev-Tov H (2016) Epidemiology and treatment of angiolymphoid hyperplasia with eosinophilia (ALHE): a systematic review. J Am Acad Dermatol 74(3):506-12e11","journal-title":"J Am Acad Dermatol"},{"key":"5985_CR26","doi-asserted-by":"publisher","DOI":"10.1093\/ced\/llaf289","author":"H Jie Yang","year":"2025","unstructured":"Jie Yang H, Nguyen J, Simpson I, Lee S, Lai FYX (2025) A case of angiolymphoid hyperplasia with eosinophilia successfully treated with dupilumab. Clin Exp Dermatol. https:\/\/doi.org\/10.1093\/ced\/llaf289","journal-title":"Clin Exp Dermatol"},{"issue":"3","key":"5985_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.annder.2025.103390","volume":"152","author":"MF Ortiz-Nu\u00f1o","year":"2025","unstructured":"Ortiz-Nu\u00f1o MF, Esquivel-Valerio JA, Garc\u00eda-Lozano JA, Galarza-Delgado DA, de la Cardenas- Garza JA (2025) Angiolymphoid hyperplasia with eosinophilia treated with dupilumab in a biologic-na\u00efve patient. Ann Dermatol Venereol 152(3):103390","journal-title":"Ann Dermatol Venereol"},{"issue":"1","key":"5985_CR28","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2025.2485262","volume":"36","author":"Y Jiang","year":"2025","unstructured":"Jiang Y, Xiao Y, Wang Y, Shang P (2025) Angiolymphoid hyperplasia with eosinophilia responded well to dupilumab in two cases. J Dermatolog Treat 36(1):2485262","journal-title":"J Dermatolog Treat"},{"issue":"1","key":"5985_CR29","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1182\/hematology.2024000584","volume":"2024","author":"LYC Chen","year":"2024","unstructured":"Chen LYC (2024) IgG4-related disease for the hematologist. Hematol Am Soc Hematol Educ Program 2024(1):594\u2013603","journal-title":"Hematol Am Soc Hematol Educ Program"},{"issue":"5","key":"5985_CR30","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1111\/his.14428","volume":"79","author":"X Wang","year":"2021","unstructured":"Wang X, Ng CS, Yin W (2021) A comparative study of Kimura\u2019s disease and IgG4-related disease: similarities, differences and overlapping features. Histopathology 79(5):801\u2013809","journal-title":"Histopathology"},{"issue":"2","key":"5985_CR31","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.jaci.2022.03.034","volume":"150","author":"R Munemura","year":"2022","unstructured":"Munemura R, Maehara T, Murakami Y et al (2022) Distinct disease-specific Tfh cell populations in 2 different fibrotic diseases: IgG(4)-related disease and Kimura disease. J Allergy Clin Immunol 150(2):440\u201355.e17","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"5985_CR32","doi-asserted-by":"publisher","first-page":"444","DOI":"10.3324\/haematol.2018.205526","volume":"104","author":"LYC Chen","year":"2019","unstructured":"Chen LYC, Mattman A, Seidman MA, Carruthers MN (2019) IgG4-related disease: what a hematologist needs to know. Haematologica 104(3):444\u2013455","journal-title":"Haematologica"},{"issue":"6","key":"5985_CR33","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1136\/annrheumdis-2014-206605","volume":"74","author":"MN Carruthers","year":"2015","unstructured":"Carruthers MN, Topazian MD, Khosroshahi A et al (2015) Rituximab for IgG4-related disease: a prospective, open-label trial. Ann Rheum Dis 74(6):1171\u20131177","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"5985_CR34","doi-asserted-by":"publisher","first-page":"e68","DOI":"10.1111\/bjh.16332","volume":"188","author":"C Choi","year":"2020","unstructured":"Choi C, Moller D, Tan J et al (2020) Pegylated interferon alpha 2a is an effective and well-tolerated treatment option for lymphocyte-variant hypereosinophilic syndrome. Br J Haematol 188(5):e68\u2013e72","journal-title":"Br J Haematol"},{"key":"5985_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2023.109275","volume":"251","author":"S Faguer","year":"2023","unstructured":"Faguer S, Groh M, Vergez F et al (2023) Jak inhibition for CD3(-) CD4(+) lymphocytic-variant hypereosinophilic syndrome. Clin Immunol 251:109275","journal-title":"Clin Immunol"},{"issue":"5","key":"5985_CR36","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1111\/bjh.17615","volume":"195","author":"AK Williams","year":"2021","unstructured":"Williams AK, Dou C, Chen LYC (2021) Treatment of lymphocyte-variant hypereosinophilic syndrome (L-HES): what to consider after confirming the elusive diagnosis. Br J Haematol 195(5):669\u2013680","journal-title":"Br J Haematol"},{"issue":"8","key":"5985_CR37","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/j.jdcr.2019.05.026","volume":"5","author":"C Dou","year":"2019","unstructured":"Dou C, Chen LYC, Dutz JP (2019) Lymphocyte-variant hypereosinophilic syndrome presenting as chronic dermatitis and responding to mycophenolic acid. JAAD Case Rep 5(8):660\u2013662","journal-title":"JAAD Case Rep"},{"issue":"5","key":"5985_CR38","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.jdcr.2017.04.010","volume":"3","author":"K Shah","year":"2017","unstructured":"Shah K, Tran AN, Magro CM, Zang JB (2017) Treatment of Kimura disease with mycophenolate mofetil monotherapy. JAAD Case Rep 3(5):416\u2013419","journal-title":"JAAD Case Rep"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-025-05985-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00296-025-05985-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-025-05985-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T10:14:32Z","timestamp":1760523272000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00296-025-05985-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,9]]},"references-count":38,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2025,9]]}},"alternative-id":["5985"],"URL":"https:\/\/doi.org\/10.1007\/s00296-025-05985-2","relation":{},"ISSN":["1437-160X"],"issn-type":[{"type":"electronic","value":"1437-160X"}],"subject":[],"published":{"date-parts":[[2025,9,9]]},"assertion":[{"value":"21 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"224"}}